We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single Vial Transport for Intestinal Parasites Launched

By LabMedica International staff writers
Posted on 17 Jun 2015
Print article
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
A one-vial, multipurpose, transport solution for the collection, transportation, preservation and examination of intestinal parasites in stool specimens has been launched.

Traditional ova and parasite examination procedures, as well as fecal antigen immunoassay tests, require different types of preservatives/transports to run a complete parasitological examination.

The new transport medium allows laboratorians to perform all of the testing from one vial, a significant improvement over multi-vial systems. Stool specimens preserved in Para-Pak SVT (Meridian Bioscience, Inc.; Cincinnati, OH, USA) can be used for direct examination, concentration, permanent stain and will not interfere with fecal immunoassays. The new Para-Pak SVT (Single Vial Transport) is also mercury, polyvinyl-alcohol (PVA) and formalin free, a more eco-friendly alternative for the laboratories when it comes to handling and disposal. As experts in parasitology and leaders in pre-analytic collection systems, including stool collection and transport systems, Meridian Bioscience continues to develop innovative products that meet the needs of today's healthcare providers.

Michael C. Shaughnessy, Executive Vice President and President Meridian Global Diagnostics, said, “Over 20,000,000 stool transport systems are used in the USA annually and the development of Para-Pak SVT provides a simplified solution for healthcare providers by offering a one patient–one transport vial approach that helps reduce potential errors associated with traditional multi-vial systems, and also offers improved work-flow options for laboratories. This is a single transport system that is cost effective and adds testing flexibility to the lab, allowing them to perform from ova and parasite (O&P) examination and fecal immunoassays from one vial.”

Related Links:

Meridian Bioscience, Inc. 


Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Vibrio Cholerae O1/O139 Rapid Test
StrongStep Vibrio Cholerae O1/O139 Antigen Combo Rapid Test
New
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.